share_log

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TESS, STSA, CHRA

PR Newswire ·  May 3, 2023 11:06

NEW YORK, May 3, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

TESSCO Technologies Incorporated (NASDAQ: TESS)'s sale to affiliates of Lee Equity Partners and Twin Point Capital for $9.00 in cash per share. If you are a TESSCO shareholder, click here to learn more about your rights and options.

Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA)'s sale to Shin Nippon Biomedical Laboratories, Ltd. for $0.91 in cash per share at the closing of the transaction plus one non-tradeable contingent value right of up to $5.77 per share. If you are a Satsuma shareholder, click here to learn more about your rights and options.

Charah Solutions, Inc. (OTC: CHRA)'s sale to SER Capital Partners for $6.00 per share. If you are a Charah shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]

SOURCE Halper Sadeh LLP

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment